Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard M Neve

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Chemical Research in Toxicology|June 18, 2019
Cell Lines as Biological Models: Practical Steps for More Reliable ResearchAmanda Capes-Davis, Amos Bairoch, Tanya Barrett, et al.
Cancer Cell|October 10, 2018
Pharmacological Induction of RAS-GTP Confers RAF Inhibitor Sensitivity in KRAS Mutant TumorsIvana Yen, Frances Shanahan, Mark Merchant, et al.
BMC Medicine|December 17, 2009
A systems analysis of the chemosensitivity of breast cancer cells to the polyamine analogue PG-11047Wen-Lin Kuo, Debopriya Das, Safiyyah Ziyad, et al.
International Journal of Cancer|September 24, 2017
Authentication of M14 melanoma cell line proves misidentification of MDA-MB-435 breast cancer cell lineChristopher Korch, Erin M Hall, Wilhelm G Dirks, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 28, 2009
Integrative analysis of cyclin protein levels identifies cyclin b1 as a classifier and predictor of outcomes in breast cancerRoshan Agarwal, Ana-Maria Gonzalez-Angulo, Simen Myhre, et al.
Clinical Proteomics|June 22, 2011
A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the Functional Proteome in Non-microdissected Human Breast CancersBryan T Hennessy, Yiling Lu, Ana Maria Gonzalez-Angulo, et al.
Cancer Cell|December 13, 2006
Genomic and transcriptional aberrations linked to breast cancer pathophysiologiesKoei Chin, Sandy DeVries, Jane Fridlyand, et al.
Cancer Research|August 5, 2008
An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancerKatherine Stemke-Hale, Ana Maria Gonzalez-Angulo, Ana Lluch, et al.
Cancer Research|January 17, 2009
Basal subtype and MAPK/ERK kinase (MEK)-phosphoinositide 3-kinase feedback signaling determine susceptibility of breast cancer cells to MEK inhibitionOlga K Mirzoeva, Debopriya Das, Laura M Heiser, et al.
Cancer Cell|December 13, 2006
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypesRichard M Neve, Koei Chin, Jane Fridlyand, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Chemical Research in Toxicology|June 18, 2019
Cell Lines as Biological Models: Practical Steps for More Reliable ResearchAmanda Capes-Davis, Amos Bairoch, Tanya Barrett, et al.
Cancer Cell|October 10, 2018
Pharmacological Induction of RAS-GTP Confers RAF Inhibitor Sensitivity in KRAS Mutant TumorsIvana Yen, Frances Shanahan, Mark Merchant, et al.
BMC Medicine|December 17, 2009
A systems analysis of the chemosensitivity of breast cancer cells to the polyamine analogue PG-11047Wen-Lin Kuo, Debopriya Das, Safiyyah Ziyad, et al.
International Journal of Cancer|September 24, 2017
Authentication of M14 melanoma cell line proves misidentification of MDA-MB-435 breast cancer cell lineChristopher Korch, Erin M Hall, Wilhelm G Dirks, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 28, 2009
Integrative analysis of cyclin protein levels identifies cyclin b1 as a classifier and predictor of outcomes in breast cancerRoshan Agarwal, Ana-Maria Gonzalez-Angulo, Simen Myhre, et al.
Clinical Proteomics|June 22, 2011
A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the Functional Proteome in Non-microdissected Human Breast CancersBryan T Hennessy, Yiling Lu, Ana Maria Gonzalez-Angulo, et al.
Cancer Cell|December 13, 2006
Genomic and transcriptional aberrations linked to breast cancer pathophysiologiesKoei Chin, Sandy DeVries, Jane Fridlyand, et al.
Cancer Research|August 5, 2008
An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancerKatherine Stemke-Hale, Ana Maria Gonzalez-Angulo, Ana Lluch, et al.
Cancer Research|January 17, 2009
Basal subtype and MAPK/ERK kinase (MEK)-phosphoinositide 3-kinase feedback signaling determine susceptibility of breast cancer cells to MEK inhibitionOlga K Mirzoeva, Debopriya Das, Laura M Heiser, et al.
Cancer Cell|December 13, 2006
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypesRichard M Neve, Koei Chin, Jane Fridlyand, et al.
Pageof 5